19 October 2020 - Covid beneficiary?
It is hardly surprising that AIM-listed Tristel has produced excellent results for the year to 30 June 2020 given the fact that it manufactures infection prevention and contamination control products. Revenues increased by 21% to £31.7m with pre-tax profits up by 27% to £7.1m. Earnings per share rose 11% to 12.35p and the dividend was increased by 12% to 6.18p. Net cash at the year end had risen to £6.2m from £4.2m a year earlier. These are clearly excellent figures but the share price looks to be . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.